Insider · CIK 0001822991

Stewart Christopher P.

Reports to the SEC for 2 companies · GOLETA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001822991

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	ALMUAeluma, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−5,697 sh	$12.36	−$70.4K	67,781
2026-09-21	ALMUAeluma, Inc.A Award	Chief Financial Officer	AAward	+15.9K sh	—	—	15,886
2026-09-21	ALMUAeluma, Inc.A Award	Chief Financial Officer	AAward	+4,042 sh	—	—	19,928
2026-09-21	ALMUAeluma, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−1,450 sh	$13.61	−$19.7K	18,478
2026-09-21	ALMUAeluma, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+37.6K sh	—	—	37,568
2023-05-12	BNGOBionano Genomics, Inc.P Purchase	Chief Financial Officer	PPurchase	+50K sh	$0.67	+$33.4K	281,373
2023-02-15	BNGOBionano Genomics, Inc.A Award	Chief Financial Officer	AAward	+105K sh	—	—	231,373
2023-02-15	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+490K sh	—	—	490,000
2022-05-13	BNGOBionano Genomics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+60K sh	$0.56	+$33.6K	121,579
2022-05-13	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−60K sh	—	—	117,500
2022-02-15	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+550K sh	—	—	550,000
2021-11-19	BNGOBionano Genomics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+22.5K sh	$0.56	+$12.6K	55,500
2021-11-19	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−22.5K sh	—	—	177,500
2021-05-26	BNGOBionano Genomics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+25K sh	$0.56	+$14K	33,000
2021-05-26	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−25K sh	—	—	200,000
2021-04-01	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+275K sh	—	—	275,000
2021-01-22	BNGOBionano Genomics, Inc.A Award	Chief Financial Officer	AAward	+8,000 sh	$6.00	+$48K	8,000
2020-09-01	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+350K sh	—	—	350,000
2020-09-01	BNGOBionano Genomics, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+225K sh	—	—	225,000

Recent filings

Accepted (ET)
Oct 14
Stewart Christopher P.0001822991-26-000005
SEC(opens sec.gov)
Sep 234
Stewart Christopher P.0001822991-26-000003
SEC(opens sec.gov)
May 164
Stewart Christopher P.0001411690-23-000031
SEC(opens sec.gov)
Feb 174
Stewart Christopher P.0001209191-23-010918
SEC(opens sec.gov)
May 164
Stewart Christopher P.0001209191-22-029459
SEC(opens sec.gov)
Feb 154
Stewart Christopher P.0001209191-22-010054
SEC(opens sec.gov)
Nov 234
Stewart Christopher P.0001209191-21-066283
SEC(opens sec.gov)
May 274
Stewart Christopher P.0001209191-21-036254
SEC(opens sec.gov)
Apr 24
Stewart Christopher P.0001209191-21-024790
SEC(opens sec.gov)
Jan 254
Stewart Christopher P.0001209191-21-005082
SEC(opens sec.gov)
Sep 34
Stewart Christopher P.0001209191-20-049303
SEC(opens sec.gov)

Companies

Address

27 CASTILIAN DRIVE

GOLETA, CA, 93117